Characterization of CMV-specific CD4+ T-cell reconstitution following stem cell transplantation through the use of HLA Class II-peptide tetramers identifies patients at high risk of recurrent CMV reactivation

Mohammad Raeiszadeh; Annette Pachnio; Jusnara Begum; Charles Craddock; Paul Moss; Frederick E Chen

doi:10.3324/haematol.2015.123687

Characterization of CMV-specific CD4+ T-cell reconstitution following stem cell transplantation through the use of HLA Class II-peptide tetramers identifies patients at high risk of recurrent CMV reactivation

Mohammad Raeiszadeh, Annette Pachnio, Jusnara Begum, Charles Craddock, Paul Moss, Frederick E Chen

Research output: Contribution to journal › Article › peer-review

6 Citations (Scopus)

Original language	English
Pages (from-to)	e318-22
Journal	Haematologica
Volume	100
Issue number	8
DOIs	https://doi.org/10.3324/haematol.2015.123687
Publication status	Published - Aug 2015

Access to Document

10.3324/haematol.2015.123687Licence: Creative Commons: Attribution (CC BY)

A Multi-Disciplinary Approach to Understanding the Immunological Basis and Potential Prevention of Graft versus Host Disease
Moss, P. (Principal Investigator), Malladi, R. (Co-Investigator), Craddock, C. (Co-Investigator), Pratt, G. (Co-Investigator), Smith, D. (Co-Investigator) & Tino, P. (Co-Investigator)
Medical Research Council
1/10/13 → 30/06/18
Project: Research Councils
Cellular Immunity to Herpesvirus Infections: Studies with Epstein-Barr Virus (EBV) and Human Cytomegalovirus (CMV)
Rickinson, A. (Principal Investigator), Moss, P. (Co-Investigator) & Rowe, M. (Co-Investigator)
Medical Research Council
1/09/10 → 31/08/15
Project: Research Councils

Cite this

Raeiszadeh, M., Pachnio, A., Begum, J., Craddock, C., Moss, P., & Chen, F. E. (2015). Characterization of CMV-specific CD4+ T-cell reconstitution following stem cell transplantation through the use of HLA Class II-peptide tetramers identifies patients at high risk of recurrent CMV reactivation. Haematologica, 100(8), e318-22. https://doi.org/10.3324/haematol.2015.123687

@article{1bbf9b3a761b4a79878e74993cc0c8a3,

title = "Characterization of CMV-specific CD4+ T-cell reconstitution following stem cell transplantation through the use of HLA Class II-peptide tetramers identifies patients at high risk of recurrent CMV reactivation",

author = "Mohammad Raeiszadeh and Annette Pachnio and Jusnara Begum and Charles Craddock and Paul Moss and Chen, {Frederick E}",

year = "2015",

month = aug,

doi = "10.3324/haematol.2015.123687",

language = "English",

volume = "100",

pages = "e318--22",

journal = "Haematologica",

issn = "0390-6078",

publisher = "Ferrata Storti Foundation",

number = "8",

}

Raeiszadeh, M, Pachnio, A, Begum, J, Craddock, C, Moss, P & Chen, FE 2015, 'Characterization of CMV-specific CD4+ T-cell reconstitution following stem cell transplantation through the use of HLA Class II-peptide tetramers identifies patients at high risk of recurrent CMV reactivation', Haematologica, vol. 100, no. 8, pp. e318-22. https://doi.org/10.3324/haematol.2015.123687

Characterization of CMV-specific CD4+ T-cell reconstitution following stem cell transplantation through the use of HLA Class II-peptide tetramers identifies patients at high risk of recurrent CMV reactivation. / Raeiszadeh, Mohammad; Pachnio, Annette; Begum, Jusnara et al.
In: Haematologica, Vol. 100, No. 8, 08.2015, p. e318-22.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - Characterization of CMV-specific CD4+ T-cell reconstitution following stem cell transplantation through the use of HLA Class II-peptide tetramers identifies patients at high risk of recurrent CMV reactivation

AU - Raeiszadeh, Mohammad

AU - Pachnio, Annette

AU - Begum, Jusnara

AU - Craddock, Charles

AU - Moss, Paul

AU - Chen, Frederick E

PY - 2015/8

Y1 - 2015/8

U2 - 10.3324/haematol.2015.123687

DO - 10.3324/haematol.2015.123687

M3 - Article

C2 - 25975839

SN - 0390-6078

VL - 100

SP - e318-22

JO - Haematologica

JF - Haematologica

IS - 8

ER -

Characterization of CMV-specific CD4+ T-cell reconstitution following stem cell transplantation through the use of HLA Class II-peptide tetramers identifies patients at high risk of recurrent CMV reactivation

Access to Document

Projects

A Multi-Disciplinary Approach to Understanding the Immunological Basis and Potential Prevention of Graft versus Host Disease

Cellular Immunity to Herpesvirus Infections: Studies with Epstein-Barr Virus (EBV) and Human Cytomegalovirus (CMV)

Cite this